hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06356870, orgStudyIdInfo id: BUE, briefTitle: Alveolar Cleft Reconstruction Using Bone Marrow Aspirate Concentrate and Allograft vs Iliac Cancellous Bone., acronym: BMAC, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-06-01, primaryCompletionDateStruct date: 2025-06-01, completionDateStruct date: 2026-06-01, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Cairo University, class: OTHER, descriptionModule briefSummary: radiographic and clinical assessment of alveolar cleft grafting using Allograft mixed with BMAC compared to the standard protocol of anterior iliac crest cancellous bone grafting, conditionsModule conditions: Alveolar Cleft Grafting, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: parallel assignment, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: BMAC MIXED WITH ALLOGRAFT, interventions name: Cancellous bone from anterior iliac crest, outcomesModule primaryOutcomes measure: bone density, secondaryOutcomes measure: Bone gain, secondaryOutcomes measure: Postoperative donor site morbidity, eligibilityModule sex: ALL, minimumAge: 8 Years, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Cairo university, city: Cairo, country: Egypt, geoPoint lat: 30.06263, lon: 31.24967, hasResults: False
protocolSection identificationModule nctId: NCT06356857, orgStudyIdInfo id: H-23070312, briefTitle: Assessing Repeatability and Intra-individual Variability in [O15]H2O-PET Myocardial Perfusion Imaging, acronym: Heart-Wave, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2024-10, completionDateStruct date: 2024-10, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-11, sponsorCollaboratorsModule leadSponsor name: Peter Hovind, class: OTHER, descriptionModule briefSummary: This study wish to assess the reproducibility of baseline and hyperemic myocardial blood flow as well as myocardial blood flow reserve measurements with \[O15\]H2O-PET-MPI., conditionsModule conditions: Myocardial Blood Flow, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: PROSPECTIVE, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: Myocardial perfusion imaging (MPI) using [O15]H2O-PET-CT, outcomesModule primaryOutcomes measure: [O15]H2O-PET-MPI variability and repeatability coefficient estimated from 20 patients having [O15]H2O-PET-MPI done twice, eligibilityModule sex: ALL, minimumAge: 50 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Bispebjerg Hospital, city: Copenhagen, state: RegionH, zip: 2400, country: Denmark, contacts name: Laila Seidelin, MD, role: CONTACT, phone: +4520353008, email: laila.seidelin.01@regionh.dk, contacts name: Martin Krakauer, MD, Phd., role: CONTACT, email: martin.krakauer@regionh.dk, contacts name: Laila Seidelin, MD, role: SUB_INVESTIGATOR, contacts name: Martin Krakauer, MD, P.hd, role: SUB_INVESTIGATOR, geoPoint lat: 55.67594, lon: 12.56553, hasResults: False
protocolSection identificationModule nctId: NCT06356818, orgStudyIdInfo id: E-74555795-050.04-941155, briefTitle: Comparison of Virtual Reality and Motor Imagery Applications in Patients With Ankle Instability, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2024-07, completionDateStruct date: 2024-09, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Istanbul University - Cerrahpasa (IUC), class: OTHER, descriptionModule briefSummary: In this study, the effects of different treatment methods for ankle instability patients are being compared aiming to find the optimal treatment. Via comparing virtual reality, motor imagery, and classic rehabilitation programs to clarify their effects on ankle static and dynamic balance, proprioception, range of motion, muscle strength, pain, function and patient satisfaction., conditionsModule conditions: Ankle Sprains, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: three groups with a conventional therapy control group., primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: Conventional physiotherapy program, interventions name: Virtual reality (VR), interventions name: Motor imagery (MI), outcomesModule primaryOutcomes measure: Visual Analog Scale (VAS), primaryOutcomes measure: Pressure Pain Threshold (PPT), primaryOutcomes measure: Star Excursion Balance Test (SEBT), primaryOutcomes measure: Single Leg Balance Test (SLBT), primaryOutcomes measure: Joint position sense (JPS), primaryOutcomes measure: Range of Motion (ROM), primaryOutcomes measure: Muscle strength, secondaryOutcomes measure: Cumberland ankle instability questionnaire (CAIT), secondaryOutcomes measure: Patient satisfaction, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 39 Years, stdAges: ADULT, contactsLocationsModule locations facility: Istanbul University-Cerrahpasa (IUC), city: Istanbul, country: Turkey, contacts name: Doaa HAKAM, PT, role: CONTACT, phone: +905345456224, email: d.hakam@ogr.iuc.edu.tr, contacts name: YILDIZ AKBABA, Assoc. Prof., role: CONTACT, email: yildizanalay@iuc.edu.tr, geoPoint lat: 41.01384, lon: 28.94966, hasResults: False
protocolSection identificationModule nctId: NCT06356805, orgStudyIdInfo id: rTMS in Fibromyalgia, briefTitle: rTMS Effect on Cognitive and Psychiatric Dysfunction in Patients With Fibromyalgia, acronym: rTMS, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-01-10, primaryCompletionDateStruct date: 2024-01-30, completionDateStruct date: 2024-02-20, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, collaborators name: Tanta University, descriptionModule briefSummary: the aim of this work was to evaluate the effect of low frequency rTMS over the right dorsolateral prefrontal area (DLPFC) on Fibromyalgia patients. Fibromyalgia Impact Questionnaire (FIQ), Hamilton depression and Anxiety scale and different cognitive rating scales were evaluated pre-1 month post sessions and pre -post 3 months later. all eligible patients with fibromyalgia (FM) were randomized to have 20 sessions of active or sham rTMS over right DLPFC. The improvement changes in groups were compared in each rating scale., conditionsModule conditions: Treatment Resistant Disorders, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 42, type: ACTUAL, armsInterventionsModule interventions name: repetitive transcranial magnetic stimulation, outcomesModule primaryOutcomes measure: 1- Assessment of Fibromyalgia Impact Questionnaire (FIQ), secondaryOutcomes measure: 1-Assessment of Hamilton depression (HDRS) and Hamilton Anxiety scales (HARS) (pre- post sessions and pre post three months), secondaryOutcomes measure: Assessment of different cognitive rating scales (Montreal cognitive Assessment scale (MoCa), and Rey Auditory Verbal Learning Test [RAVLT],, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule locations facility: Eman Khedr, city: Assiut, zip: 11517, country: Egypt, geoPoint lat: 27.18096, lon: 31.18368, hasResults: False
protocolSection identificationModule nctId: NCT06356792, orgStudyIdInfo id: Obstetrics outcome in Abortion, briefTitle: Obstetrics, Prenatal Outcomes in Recurrent Miscarriage, acronym: OBPORPL, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-21, primaryCompletionDateStruct date: 2025-03-21, completionDateStruct date: 2025-03-21, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, descriptionModule briefSummary: The effect of recurrent miscarriage on the outcome of the current pregnancy and if there's a relation between it and adverse out come, conditionsModule conditions: Recurrent Miscarriage, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: OTHER, enrollmentInfo count: 102, type: ESTIMATED, outcomesModule primaryOutcomes measure: If there's relation between recurrent abortion and having a medical disorder during current pregnancy, eligibilityModule sex: FEMALE, minimumAge: 17 Years, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Assiut University, status: RECRUITING, city: Assiut, country: Egypt, geoPoint lat: 27.18096, lon: 31.18368, hasResults: False
protocolSection identificationModule nctId: NCT06356753, orgStudyIdInfo id: RC19_0203, briefTitle: EndoxOmics : Exposome, Endometriosis and Fertility, acronym: EndoxOmics, statusModule overallStatus: COMPLETED, startDateStruct date: 2019-09-01, primaryCompletionDateStruct date: 2021-03-31, completionDateStruct date: 2021-03-31, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Nantes University Hospital, class: OTHER, descriptionModule briefSummary: For several years, the effects of environmental pollution on human health have been a growing concern for the scientific community and public authorities. Among the many known chemical contaminants, persistent organic pollutants (POPs) are of particular concern because of their properties as endocrine disrupters, bioaccumulation and biomagnification. The associations between environmental pollutants, endometriosis and infertility remains poorly understood. The objective of this exploratory non interventional monocentric study conducted in the University Hospital of Nantes, is to identify endogenous molecular profiles associated with endometriosis and related infertility. This project implements an exploratory approach combining exposure and metabolomics approaches based on high-resolution mass spectrometry to identify exposure and metabolomics profiles associated with infertility, and biomarkers for potential prognostic application., conditionsModule conditions: Endometriosis, conditions: Infertility, Female, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 87, type: ACTUAL, armsInterventionsModule, outcomesModule primaryOutcomes measure: Identify endogenous molecular profiles of patients with infertile endometriosis, secondaryOutcomes measure: Characterize the internal chemical exposure profiles and metabolomic profiles in the different groups., secondaryOutcomes measure: Compare the distribution of contaminant concentration levels and metabolomic profiles according to the media measured., eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 45 Years, stdAges: ADULT, contactsLocationsModule locations facility: Nantes University Hospital, city: Nantes, state: Loire-Atlantique, zip: 44093, country: France, geoPoint lat: 47.21725, lon: -1.55336, hasResults: False
protocolSection identificationModule nctId: NCT06356714, orgStudyIdInfo id: 13914704179, briefTitle: Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2025-05-01, completionDateStruct date: 2025-08-01, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Sun Jing, class: OTHER, descriptionModule briefSummary: Evaluate the efficacy and safety of Nocardia rubra cell wall skeleton in combination with prior second- or third-line regimens for the treatment of potentially hazardous colorectal cancer SD(Stable Disease) status in the real world., conditionsModule conditions: Colorectal Cancer, conditions: Colorectal Neoplasms, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 22, type: ESTIMATED, armsInterventionsModule interventions name: Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens, outcomesModule primaryOutcomes measure: Progression-free survival(PFS), secondaryOutcomes measure: Overall survival (OS), secondaryOutcomes measure: Objective remission rate (ORR), secondaryOutcomes measure: Disease Control Rate (DCR), secondaryOutcomes measure: Incidence and extent of major security incidents, secondaryOutcomes measure: Quality of Life Score (QoL) for tumor patients, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06356701, orgStudyIdInfo id: dongyandl, briefTitle: Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-04-15, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-12-31, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: The First Affiliated Hospital of Dalian Medical University, class: OTHER, descriptionModule briefSummary: A Single-center, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Tumor Nutritional Therapy Combined With Immune Checkpoint Inhibitors and Chemotherapy in the First-line Treatment of Stage IV NSCLC Without Driver Gene Mutations, conditionsModule conditions: Long-Term Effects Secondary to Cancer Therapy, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: Cancer nutritional treatment regimen (Spirulina Bifidobacterium Capsules, Fish Oil Grape Seed Blueberry Soft Capsules, Ganoderma Spore Oil Soft Capsules), outcomesModule primaryOutcomes measure: PFS, primaryOutcomes measure: Assessment of global disorders in patients with cancer, primaryOutcomes measure: ORR, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: DongYan, status: RECRUITING, city: Dalian City, state: Liaoning, zip: 116000, country: China, contacts name: DongYan Dong, role: CONTACT, phone: 18098876750, email: dongyan979828@hotmail.com, hasResults: False
protocolSection identificationModule nctId: NCT06356688, orgStudyIdInfo id: 13914704178, briefTitle: A Clinical Study on the Efficacy and Safety of Paclitaxel Polymer Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-20, primaryCompletionDateStruct date: 2025-04-20, completionDateStruct date: 2025-06-20, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Sun Jing, class: OTHER, descriptionModule briefSummary: The purpose of this study is to investigate the efficacy and safety of neoadjuvant treatment of locally advanced esophageal squamous carcinoma with a PD-1/CTLA-4 bispecific antibody (cadonilimab) in combination with platinum-containing chemotherapy (paclitaxel polymer micelles combined with cisplatin). Includes pathologic complete remission rates (pCR rates) after 2-4 cycles of cadonilimab combination chemotherapy. The objective remission rate (ORR), major pathologic remission rate (MPR), R0 resection rate and 2-year overall survival (OS) and progression-free survival (OS) rates, and safety of neoadjuvant treatment of locally advanced esophageal squamous carcinoma with cadonilimab combined with chemotherapy., conditionsModule conditions: Locally Advanced Esophageal Squamous Cell Carcinoma, conditions: Neoadjuvant Therapy, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: paclitaxel polymer micelles and cisplatin combined with Camrelizumab, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: paclitaxel polymer micelles and cisplatin combined with Cadonilimab, outcomesModule primaryOutcomes measure: Pathological complete response (pCR) rates, secondaryOutcomes measure: Objective Rate of Effectiveness (ORR), secondaryOutcomes measure: R0 Removal Rate, secondaryOutcomes measure: 2-year overall survival rate, secondaryOutcomes measure: 2-year disease free survival rate, secondaryOutcomes measure: major pathological response (MPR), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06356675, orgStudyIdInfo id: A single-arm pilot, briefTitle: A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-07-01, primaryCompletionDateStruct date: 2028-07-01, completionDateStruct date: 2028-07-01, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, class: OTHER, descriptionModule briefSummary: Immune resistance after treatment, there is no standard treatment, one of the most important and the most effective measures is immune to combination therapy。Targeted angiogenesis therapy has always been the focus of research on the treatment of NSCLC patients with progressive disease after immunotherapy. From the mechanism of action, angiogenesis and immunosuppression are interrelated processes., conditionsModule conditions: Advanced NSCLC, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 33, type: ESTIMATED, armsInterventionsModule interventions name: Tislelizumab, interventions name: Anlotinib, outcomesModule primaryOutcomes measure: objective response rate, secondaryOutcomes measure: progression free survival time, secondaryOutcomes measure: over survival time, secondaryOutcomes measure: disease control rate, secondaryOutcomes measure: safety including any grade adverse events, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06356662, orgStudyIdInfo id: KY-2023-198, briefTitle: Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's Disease, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-23, primaryCompletionDateStruct date: 2024-08-31, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: The Fourth Affiliated Hospital of Zhejiang University School of Medicine, class: OTHER, descriptionModule briefSummary: To evaluate the efficacy and safety of tenofovir disoproxil fumarate in the treatment of Parkinson's disease. The changes of motor symptoms and the occurrence of adverse reactions in early Parkinson's disease patients who took tenofovir disoproxil fumarate and did not take Tenofovir disoproxil fumarate at different time points were compared., conditionsModule conditions: Parkinson Disease, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Tenofovir Disoproxil Fumarate, outcomesModule primaryOutcomes measure: UPDRS III（Unified Parkinson's Disease Rating Scale part 3）, secondaryOutcomes measure: Non-Motor Symptom Scale（NMSS）, secondaryOutcomes measure: creatinine(μmoI/L), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Guohua Zhao, status: RECRUITING, city: Hangzhou, state: Zhejiang, country: China, contacts name: Zhao Guohua, Doctor, role: CONTACT, phone: +86 13777812308, email: gzhao@zju.edu.cn, geoPoint lat: 30.29365, lon: 120.16142, hasResults: False
protocolSection identificationModule nctId: NCT06356649, orgStudyIdInfo id: ESOGU2, briefTitle: Investigation of the Effects of Pressure Support Ventilation and Positive Airway Pressure Modes During Extubation, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-03-15, primaryCompletionDateStruct date: 2024-01-15, completionDateStruct date: 2024-01-20, studyFirstPostDateStruct date: 2024-04-10, lastUpdatePostDateStruct date: 2024-04-10, sponsorCollaboratorsModule leadSponsor name: Eskisehir Osmangazi University, class: OTHER, descriptionModule briefSummary: Controlled ventilation is applied to patients intubated for general anesthesia. Additionally, positive end-expiratory pressure (PEEP) and pressure support are mechanical ventilation modes that have been used in general anesthesia practice for many years. When the recovery-extubation phase is reached, intermittent bag-mask ventilation is usually used and the patient is allowed to breathe spontaneously and is extubated when an adequate respiratory level is reached. It has been shown in previous studies that the use of intermittent mask ventilation causes postoperative atelectasis. Different methods have been used to prevent postoperative atelectasis. In our study, we aimed to observe the effect of terminating general anesthesia at the end of the operation and using PEEP and pressure-supported ventilation during the extubation phase on early complications., conditionsModule conditions: Anesthesia, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: PROSPECTIVE, enrollmentInfo count: 199, type: ACTUAL, armsInterventionsModule interventions name: extubation, outcomesModule primaryOutcomes measure: Complications developing during recovery-extubation, secondaryOutcomes measure: hemodynamic changes, secondaryOutcomes measure: hemodynamic data, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Eskisehir Osmangazi University Medical Faculty, city: Eskisehir, state: Odunpazarı, zip: 26040, country: Turkey, geoPoint lat: 39.77667, lon: 30.52056, hasResults: False